Symptom presentation at diagnosis as a biological risk indicator in both resectable and unresectable pancreatic ductal adenocarcinoma
Surgery Today · 2026-11 · 56 (11) · 2885-2896
DOI: 10.1007/s00595-026-03369-y ↗Kurz gefasst
Fachartikel in der Zeitschrift Surgery Today, online erschienen am 27.07.2026. Verfasst von Takahiro Tomino und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hepatobiliary and Pancreatic Surgery, NHO Kyushu Cancer Center, 3-1-1 Notame, Minami-ku, Fukuoka, 811-1395, Japan. Hauptthemen laut MEDLINE: Carcinoma, Pancreatic Ductal, Pancreatic Neoplasms. Die Arbeit nennt 34 Literaturangaben.
Abstract (Originalsprache)
PURPOSE: Symptom presentation at diagnosis is considered a surrogate marker of disease stage in pancreatic ductal adenocarcinoma (PDAC). However, its prognostic impact across resectability stages remains unclear. We evaluated whether symptoms serve as biological risk indicators using stratified analyses of surgical and non-surgical cohorts. METHODS: This retrospective single-center study included 729 patients with PDAC: non-resected (n = 519) and resected (n = 210), including 179 with anatomically resectable disease. Patients were classified as asymptomatic or symptomatic at the time of diagnosis. Overall survival (OS) was compared, and preoperative variables were assessed as independent predictors of OS. RESULTS: Symptomatic patients had a significantly worse overall survival (OS) across cohorts. In the non-resected cohort, the 3-year OS was 1.8% in symptomatic patients vs. 10.3% in asymptomatic patients (p < 0.001). In the resected cohort, the 5-year OS was 27.6% vs. 38.7% (p = 0.024). In the resectable cohort, the 5-year OS was 22.5% vs. 38.3% (p < 0.001). Symptom presentation independently predicted a poorer OS in multivariable analyses of resected patients (hazard ratio, 1.58; p = 0.024) and those with anatomically resectable disease (hazard ratio, 1.83; p = 0.015). CONCLUSIONS: Symptoms at diagnosis were associated with a poorer OS in PDAC, regardless of resectability, suggesting a simple, broadly available marker that may complement anatomical stratification.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Hepatobiliary and Pancreatic Surgery, NHO Kyushu Cancer Center, 3-1-1 Notame, Minami-ku, Fukuoka, 811-1395, Japan.
- Department of Hepatobiliary and Pancreatic Surgery, NHO Kyushu Cancer Center, 3-1-1 Notame, Minami-ku, Fukuoka, 811-1395, Japan. ksugimachi@gmail.com.
- Department of Hepato-Biliary-Pancreatology, NHO Kyushu Cancer Center, Fukuoka, Japan.
- Department of Gastroenterological Surgery, NHO Kyushu Cancer Center, Fukuoka, Japan.
Zitieren
APA
Tomino, T., Sugimachi, K., Lee, L., Kurihara, T., Onishi, E., Niina, Y., Hisano, T., Sugimoto, R., Koga, N., Kasagi, Y., Sugiyama, M., Kimura, Y., & Morita, M. (2026). Symptom presentation at diagnosis as a biological risk indicator in both resectable and unresectable pancreatic ductal adenocarcinoma. Surgery Today, 56(11), 2885-2896. https://doi.org/10.1007/s00595-026-03369-y
Vancouver
Tomino T, Sugimachi K, Lee L, Kurihara T, Onishi E, Niina Y, et al. Symptom presentation at diagnosis as a biological risk indicator in both resectable and unresectable pancreatic ductal adenocarcinoma. Surgery Today. 2026;56(11):2885-2896. doi:10.1007/s00595-026-03369-y
BibTeX
@article{Tomino2026,
author = {Tomino, Takahiro and Sugimachi, Keishi and Lee, Lingaku and Kurihara, Takeshi and Onishi, Emi and Niina, Yusuke and Hisano, Terumasa and Sugimoto, Rie and Koga, Naomichi and Kasagi, Yuta and Sugiyama, Masahiko and Kimura, Yasue and Morita, Masaru},
title = {Symptom presentation at diagnosis as a biological risk indicator in both resectable and unresectable pancreatic ductal adenocarcinoma},
journal = {Surgery Today},
year = {2026},
volume = {56},
number = {11},
pages = {2885--2896},
doi = {10.1007/s00595-026-03369-y}
}
EUVIMED